Biotech · Private company
Fortvita Biologics (USA)Inc.
Track this companyFree. Adds Fortvita Biologics (USA)Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials66 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- IBI3003Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- IBI3001Phase 1 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- IBI3020Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- IBI3032Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Investigational Drug: IBI3042Phase 1 · Healthy Volunteers (HV)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple MyelomaPHASE1_PHASE2 · RECRUITING · started Sep 30, 2026ClinicalTrials.gov NCT07336472 · fetched Nov 12, 2026
- A Study of IBI3042 in Healthy Adult ParticipantsPHASE1 · NOT_YET_RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07842393 · fetched Nov 12, 2026
- A Study of IBI3032 in Healthy ParticipantsPHASE1 · RECRUITING · started Sep 10, 2025ClinicalTrials.gov NCT07120425 · fetched Nov 12, 2026
- Study of IBI3020 Treatment in Participants With Late-Stage Solid TumorsPHASE1 · RECRUITING · started Apr 29, 2025ClinicalTrials.gov NCT06963281 · fetched Nov 12, 2026
- IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Jan 10, 2025ClinicalTrials.gov NCT06349408 · fetched Nov 12, 2026
- A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid TumorsPHASE1 · RECRUITING · started Oct 26, 2022ClinicalTrials.gov NCT05458219 · fetched Nov 12, 2026